Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

Sleep apnea linked to higher hospitalization rates in older adults

A new study to be presented at the SLEEP 2024 annual meeting found that sleep apnea is associated with increased odds of future utilization of

June 3, 2024

Xspray Pharma handed CRL from US regulators seeking more information about leukemia treatment

Xspray Pharma has been given a complete response letter from the FDA over the NDA for its leukemia treatment Dasynoc, which it had expected to

July 12, 2023

Antengene, Hansoh partner to commercialise XPOVIO in China

XPOVIO is the world’s first approved orally available selective inhibitor of the nuclear export protein XPO1. Credit: Nemes Laszlo / Shutterstock.com. Antengene has signed a

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.